Stephens Investment Management Group LLC Sells 26,174 Shares of Henry Schein, Inc. $HSIC

Stephens Investment Management Group LLC lessened its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 15.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 144,750 shares of the company’s stock after selling 26,174 shares during the period. Stephens Investment Management Group LLC’s holdings in Henry Schein were worth $10,574,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the stock. JPMorgan Chase & Co. grew its position in shares of Henry Schein by 6.5% in the 1st quarter. JPMorgan Chase & Co. now owns 6,373,036 shares of the company’s stock valued at $436,489,000 after buying an additional 390,399 shares during the last quarter. Dimensional Fund Advisors LP grew its position in shares of Henry Schein by 4.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,240,933 shares of the company’s stock valued at $153,480,000 after buying an additional 103,384 shares during the last quarter. Burgundy Asset Management Ltd. boosted its position in shares of Henry Schein by 33.9% during the 1st quarter. Burgundy Asset Management Ltd. now owns 2,235,429 shares of the company’s stock valued at $153,105,000 after purchasing an additional 566,530 shares in the last quarter. Clarkston Capital Partners LLC boosted its position in shares of Henry Schein by 0.4% during the 1st quarter. Clarkston Capital Partners LLC now owns 1,751,570 shares of the company’s stock valued at $119,965,000 after purchasing an additional 7,345 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in shares of Henry Schein by 1.0% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 1,203,676 shares of the company’s stock valued at $82,440,000 after purchasing an additional 11,999 shares in the last quarter. Institutional investors own 96.62% of the company’s stock.

Henry Schein Stock Performance

Shares of Henry Schein stock opened at $63.51 on Thursday. The company has a market cap of $7.70 billion, a PE ratio of 20.49, a price-to-earnings-growth ratio of 2.12 and a beta of 0.81. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49. The business has a 50 day moving average price of $66.90 and a 200-day moving average price of $68.53. The company has a quick ratio of 0.78, a current ratio of 1.41 and a debt-to-equity ratio of 0.51.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.09). The company had revenue of $3.24 billion during the quarter, compared to analysts’ expectations of $3.22 billion. Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The business’s revenue for the quarter was up 3.3% compared to the same quarter last year. During the same period last year, the company earned $1.23 earnings per share. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. Equities analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts recently commented on the company. Stifel Nicolaus restated a “hold” rating and set a $75.00 target price (down previously from $80.00) on shares of Henry Schein in a research report on Friday, July 25th. UBS Group cut their target price on Henry Schein from $75.00 to $70.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 6th. Weiss Ratings restated a “hold (c)” rating on shares of Henry Schein in a research report on Wednesday, October 8th. Leerink Partners set a $75.00 price target on Henry Schein in a research note on Monday, July 14th. Finally, Evercore ISI raised Henry Schein from an “in-line” rating to an “outperform” rating and set a $83.00 price target on the stock in a research note on Tuesday, August 26th. Five research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $76.67.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.